FT
Therapeutic Areas
NeuroSense Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PrimeC | Amyotrophic Lateral Sclerosis (ALS) | Phase IIb |
Leadership Team at NeuroSense Therapeutics
AB
Alon Ben-Noon
Chief Executive Officer
DS
Dr. Shiran Zimri
VP Research & Development / Chief Scientific Officer